Zhui Chen is the founder of OTR Therapeutics. OTR Therapeutics has raised $100M in total funding. Latest round: Series A. Based in Shanghai, China.
Dr. Zhui Chen is the Co-founder and CEO of OTR Therapeutics, a biotechnology company established in March 2025. OTR Therapeutics focuses on transforming early-stage innovations into globally impactful therapies, integrating internal R&D with external innovation. The company successfully completed a $100 million Series A financing round in June 2025.
Full founder directory · Investor directory · Company funding database · Fundraising library